Literature DB >> 8429047

Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors.

P J Vaughan1, D D Cunningham.   

Abstract

The clotting protease thrombin might contribute to cell damage following brain injury by its ability to retract processes on neurons and astrocytes. Protease nexin-1 (PN-1), a potent inhibitor of thrombin, is localized around cerebral blood vessels where it may protect these cells from extravasated thrombin during injury or alteration of the blood-brain barrier. Here we examined the effects of several injury-related factors on the regulation of PN-1 in cultured brain cells. Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta stimulated the secretion of PN-1 by the neuroblastoma cell line SK-N-SH. This cell line comprises both neuronal and glial cells. Analyses using cloned derivatives of these two cell types showed that PN-1 was secreted by the glial cells; PN-1 secretion was stimulated 90-fold by interleukin-1, 15-fold by tumor necrosis factor-alpha, 10-fold by tumor growth factor-beta, and 4-fold by platelet-derived growth factor. Measurements of newly synthesised PN-1 demonstrated that these factors produced an equivalent stimulation of PN-1 synthesis. The neuronal cells secreted two thrombin-binding proteins distinct from PN-1. Interactions between these two cell types regulated the secretion of PN-1 and the two thrombin-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429047

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Virchow's triad: the vascular basis of cerebral injury.

Authors:  Gregory J del Zoppo
Journal:  Rev Neurol Dis       Date:  2008

2.  Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation.

Authors:  Siva Kumar Solleti; Sorachai Srisuma; Soumyaroop Bhattacharya; Javier Rangel-Moreno; Kaiser M Bijli; Troy D Randall; Arshad Rahman; Thomas J Mariani
Journal:  FASEB J       Date:  2016-04-08       Impact factor: 5.191

3.  Association of SERPINE2 gene with the risk of chronic obstructive pulmonary disease and spirometric phenotypes in northern Han Chinese population.

Authors:  Li An; Ting Yang; Yongbiao Zhang; Yingxiang Lin; Hong Zhang; Xia Jiao; Lin Hua; Huaping Dai; Chen Wang
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

Review 4.  Cellular consequences of thrombin-receptor activation.

Authors:  R J Grand; A S Turnell; P W Grabham
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 5.  Thrombin in inflammation and healing: relevance to rheumatoid arthritis.

Authors:  R Morris; P G Winyard; D R Blake; C J Morris
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

6.  Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.

Authors:  Danmei Xu; Chad M McKee; Yunhong Cao; Yunchuan Ding; Benedikt M Kessler; Ruth J Muschel
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

7.  Neuron-generated thrombin induces a protective astrocyte response via protease activated receptors.

Authors:  Padmesh S Rajput; Jessica Lamb; Shweta Kothari; Benedict Pereira; Daniel Soetkamp; Yizhou Wang; Jie Tang; Jennifer E Van Eyk; Eric S Mullins; Patrick D Lyden
Journal:  Glia       Date:  2019-08-27       Impact factor: 7.452

8.  Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation.

Authors:  V L Turgeon; E D Lloyd; S Wang; B W Festoff; L J Houenou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

Review 9.  Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention?

Authors:  Hideki Matsuoka; Rikuzo Hamada
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

10.  SERPINE2 polymorphisms and chronic obstructive pulmonary disease.

Authors:  Seung Ick Cha; Hyo-Gyoung Kang; Jin Eun Choi; Min Jung Kim; Jaeho Park; Won Kee Lee; Chang Ho Kim; Tae Hoon Jung; Jae Yong Park
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.